Companies: 10,795·Total market cap: $144.5T
Neurogene Inc.

Neurogene Inc.

NGNENASDAQHealthcare● Active
$26.97
+$0.48(+1.79%)
Market Cap$426098234
P/E Ratio—
52W High$37.266
52W Low$14.65
SEC Filings

Neurogene Inc. (NGNE) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001404644 · NGNE · NASDAQ · as of Jun 8, 2026

Filing snapshot

732
Total Filings
8-K
Latest Form
2026-06-08
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001404644 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-24
Fiscal Year End
Mar 24, 2026
Accession No.
0001404644-26-000019
Primary Document
ngne-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001404644 · Accession 0001404644-26-000019

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-12
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-08Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-08
View
8-KCurrent Report
8-K
2026-06-04
View
8-KCurrent Report
8-K
2026-05-12
View
10-QQuarterly Report
10-Q
2026-05-12
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-04-20
View
8-KCurrent Report
8-K
2026-04-20
View
ARSARS
ARS
2026-04-16
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-16
View
DEF 14AProxy Statement
DEF 14A
2026-04-16
View
S-8Employee Stock Plan Registration
S-8
2026-03-24
View
10-KAnnual Report
10-K
2026-03-24
View
8-KCurrent Report
8-K
2026-03-24
View
8-KCurrent Report
8-K
2026-02-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
8-KCurrent Report
8-K
2026-01-12
View
Showing 1–15 of 492 filingsForm 4 / 144 hidden· 732 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001404644  |  Exchange: NASDAQ · Healthcare

Neurogene Inc. (NASDAQ: NGNE) has submitted 732 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001404644, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Neurogene Inc.'s most comprehensive regulatory disclosure. The most recent Neurogene Inc. 10-K was filed on 2026-03-24 for fiscal year ending 2026. Historical NGNE 10-K annual reports are available from 2007 through 2026.

Investors researching Neurogene Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
ALMS SEC Filings →SLDB SEC Filings →OCGN SEC Filings →PRTC SEC Filings →AUTL SEC Filings →LCTX SEC Filings →BNTC SEC Filings →QSI SEC Filings →
→ NGNE Financials→ NGNE Earnings→ NGNE Insider Trades

Frequently Asked Questions

NGNE SEC Filings · 8 questions

Neurogene Inc. (NGNE) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 732 filings and access original documents at no cost. Neurogene Inc.'s CIK is 0001404644.

NGNE SEC filingsNeurogene Inc. SEC documentsfind NGNE 10-K